+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Finasteride Market by Route Of Administration (Oral, Topical), Product Type (Branded, Generic), Strength, Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Finasteride Market by Route Of Administration (Oral, Topical), Product Type (Branded, Generic), Strength, Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Finasteride Market by Route Of Administration (Oral, Topical), Product Type (Branded, Generic), Strength, Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967736
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The finasteride market is entering a period of notable transition, shaped by evolving patient needs, technological advances in drug delivery, and an increasingly complex regulatory environment. Senior decision-makers must navigate a shifting landscape to capture value, ensure compliance, and drive sustainable growth.

Market Snapshot: Finasteride Market Size and Projected Growth

The Finasteride Market grew from USD 122.88 million in 2024 to USD 126.55 million in 2025. It is expected to continue growing at a CAGR of 2.84%, reaching USD 145.44 million by 2030. This growth is underpinned by expanding therapeutic applications and increasing patient awareness, positioning finasteride as a central component in treatments for androgenic alopecia and benign prostatic hyperplasia across global health systems.

Scope & Segmentation of the Finasteride Market

This market research offers a structured analysis across multiple dimensions:

  • Route of Administration: Oral (tablet, capsule) and topical (foam, solution) formats support diverse patient preferences and enhance adherence.
  • Product Type: Both branded (innovator, licensed) and generic (local, multinational) drugs, capturing a wide price and access spectrum.
  • Strength: 1 mg and 5 mg dosages, tailored to distinct indications such as hair loss prevention and prostate health.
  • Indication: Androgenic alopecia (male pattern baldness, female pattern hair loss) and benign prostatic hyperplasia (mild, moderate to severe).
  • Distribution Channel: Hospital pharmacy (private, public), online pharmacy (manufacturer website, third-party e-retailer), and retail pharmacy (chain, independent).
  • End User: Dermatology and urology clinics, home care/self-medication, and hospitals (private, public).
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and key EMEA markets), Asia-Pacific (including China, India, Japan, Australia, and Southeast Asia).
  • Leading Companies: Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; Viatris Inc.; Sandoz International GmbH; Dr. Reddy's Laboratories Limited; Lupin Limited; Sun Pharmaceutical Industries Limited; Cipla Limited; Aurobindo Pharma Limited; Alembic Pharmaceuticals Limited.

Key Takeaways: Strategic Insights for Market Participants

  • Finasteride’s adoption is expanding due to dual clinical roles in hair restoration and prostate condition management, giving manufacturers broad therapeutic reach.
  • The rise of generic competitors after key patent expirations is fueling competitive pricing and encouraging regional players to innovate, particularly through novel topical and delivery formats.
  • Technological integration, such as telemedicine and personalized medicine, is enhancing patient monitoring and enabling tailored treatment regimens for better outcomes.
  • Value-based contracting and risk-sharing agreements are increasingly crucial as stakeholders align pricing strategies with demonstrated therapeutic benefit and navigate reimbursement constraints.
  • Sustainability initiatives in manufacturing—from green chemistry practices to global traceability—are gaining momentum, driven by both regulatory requirements and corporate responsibility goals.
  • Collaborations between global firms and local specialists, as well as partnerships with digital health platforms, are accelerating route-to-market strategies and expanding patient access.

Anticipating the Impact of Tariff Policy Changes

Forthcoming U.S. tariff adjustments in 2025 are set to influence raw material sourcing and production cost bases. Companies may respond by accelerating diversification of supply chains, strengthening domestic partnerships, and optimizing inventory management through analytics. As pricing models adjust, value-based arrangements and predictive planning will become vital to maintaining market stability and access.

Methodology & Data Sources

This report leverages in-depth interviews with industry thought leaders, detailed reviews of regulatory and clinical evidence, as well as import and export documentation. Cross-referencing between primary and secondary sources, combined with quantitative modeling and qualitative analysis, ensures robust, actionable market intelligence.

Why This Report Matters for Senior Decision-Makers

  • Enables executives to align supply chain and market entry strategies with evolving regulatory and pricing dynamics.
  • Provides actionable segmentation and competitive insights for optimizing portfolio decisions and targeting key growth regions.
  • Supports scenario planning, risk assessment, and strategic investment by distilling major industry disruptors and innovation trends.

Conclusion

The finasteride market remains dynamic, shaped by shifting therapeutic trends, technological advancements, and global policy changes. Stakeholders equipped with timely, rigorous insights are best positioned to capture emerging opportunities and maintain competitive advantage in a rapidly evolving environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of new topical finasteride formulations to minimize systemic exposure and side effects
5.2. Expansion of telehealth platforms providing virtual finasteride consultations and prescription services
5.3. Surge in investment in generic finasteride production by contract manufacturers in emerging markets
5.4. Increasing clinical trials evaluating low-dose finasteride treatment regimens for female pattern hair loss
5.5. Rise of digital adherence monitoring solutions to track patient compliance with finasteride therapy schedules
5.6. Emergence of combination therapies pairing finasteride with topical growth factors for enhanced hair regrowth outcomes
5.7. Impact of branded finasteride patent expirations on pricing strategies and entry of value oriented generics
5.8. Growing consumer interest in alternative androgen inhibitors and natural finasteride analogs for hair loss prevention
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Finasteride Market, by Route Of Administration
8.1. Introduction
8.2. Oral
8.2.1. Capsule
8.2.2. Tablet
8.3. Topical
8.3.1. Foam
8.3.2. Solution
9. Finasteride Market, by Product Type
9.1. Introduction
9.2. Branded
9.2.1. Innovator Brands
9.2.2. Licensed Brands
9.3. Generic
9.3.1. Local Manufacturer
9.3.2. Multinational Manufacturer
10. Finasteride Market, by Strength
10.1. Introduction
10.2. 1 Mg
10.3. 5 Mg
11. Finasteride Market, by Indication
11.1. Introduction
11.2. Androgenic Alopecia
11.2.1. Female Pattern Hair Loss
11.2.2. Male Pattern Baldness
11.3. Benign Prostatic Hyperplasia
11.3.1. Mild BPH
11.3.2. Moderate To Severe BPH
12. Finasteride Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Private Hospital
12.2.2. Public Hospital
12.3. Online Pharmacy
12.3.1. Manufacturer Website
12.3.2. Third Party E-Retailer
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Finasteride Market, by End User
13.1. Introduction
13.2. Clinics
13.2.1. Dermatology Clinics
13.2.2. Urology Clinics
13.3. Home Care
13.3.1. Self Medication
13.4. Hospitals
13.4.1. Private Hospitals
13.4.2. Public Hospitals
14. Americas Finasteride Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Finasteride Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Finasteride Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Merck & Co., Inc.
17.3.2. Teva Pharmaceutical Industries Ltd.
17.3.3. Viatris Inc.
17.3.4. Sandoz International GmbH
17.3.5. Dr. Reddy's Laboratories Limited
17.3.6. Lupin Limited
17.3.7. Sun Pharmaceutical Industries Limited
17.3.8. Cipla Limited
17.3.9. Aurobindo Pharma Limited
17.3.10. Alembic Pharmaceuticals Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. FINASTERIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. FINASTERIDE MARKET: RESEARCHAI
FIGURE 28. FINASTERIDE MARKET: RESEARCHSTATISTICS
FIGURE 29. FINASTERIDE MARKET: RESEARCHCONTACTS
FIGURE 30. FINASTERIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FINASTERIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FINASTERIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FINASTERIDE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FINASTERIDE MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FINASTERIDE MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FINASTERIDE MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FINASTERIDE MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FINASTERIDE MARKET SIZE, BY FOAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FINASTERIDE MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FINASTERIDE MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FINASTERIDE MARKET SIZE, BY INNOVATOR BRANDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FINASTERIDE MARKET SIZE, BY INNOVATOR BRANDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FINASTERIDE MARKET SIZE, BY LICENSED BRANDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FINASTERIDE MARKET SIZE, BY LICENSED BRANDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FINASTERIDE MARKET SIZE, BY LOCAL MANUFACTURER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FINASTERIDE MARKET SIZE, BY LOCAL MANUFACTURER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FINASTERIDE MARKET SIZE, BY MULTINATIONAL MANUFACTURER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FINASTERIDE MARKET SIZE, BY MULTINATIONAL MANUFACTURER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FINASTERIDE MARKET SIZE, BY 1 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FINASTERIDE MARKET SIZE, BY 1 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FINASTERIDE MARKET SIZE, BY 5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FINASTERIDE MARKET SIZE, BY 5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FINASTERIDE MARKET SIZE, BY FEMALE PATTERN HAIR LOSS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FINASTERIDE MARKET SIZE, BY FEMALE PATTERN HAIR LOSS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FINASTERIDE MARKET SIZE, BY MALE PATTERN BALDNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FINASTERIDE MARKET SIZE, BY MALE PATTERN BALDNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FINASTERIDE MARKET SIZE, BY MILD BPH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FINASTERIDE MARKET SIZE, BY MILD BPH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FINASTERIDE MARKET SIZE, BY MODERATE TO SEVERE BPH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FINASTERIDE MARKET SIZE, BY MODERATE TO SEVERE BPH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL FINASTERIDE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL FINASTERIDE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL FINASTERIDE MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL FINASTERIDE MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL FINASTERIDE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL FINASTERIDE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL FINASTERIDE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL FINASTERIDE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL FINASTERIDE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL FINASTERIDE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL FINASTERIDE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL FINASTERIDE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL FINASTERIDE MARKET SIZE, BY SELF MEDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL FINASTERIDE MARKET SIZE, BY SELF MEDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. CANADA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. CANADA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 200. CANADA FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 201. CANADA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 204. CANADA FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 205. CANADA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 206. CANADA FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 207. CANADA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. CANADA FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. CANADA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 212. CANADA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 213. CANADA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 214. CANADA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 215. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. CANADA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. CANADA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. CANADA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. CANADA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. CANADA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. CANADA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. CANADA FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. CANADA FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. CANADA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. CANADA FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. CANADA FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 228. CANADA FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 229. CANADA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. CANADA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. MEXICO FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. MEXICO FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 234. MEXICO FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 235. MEXICO FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 236. MEXICO FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 237. MEXICO FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 240. MEXICO FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 241. MEXICO FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 242. MEXICO FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 243. MEXICO FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. MEXICO FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. MEXICO FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 248. MEXICO FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 249. MEXICO FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 250. MEXICO FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 251. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. MEXICO FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. MEXICO FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. MEXICO FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. MEXICO FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. MEXICO FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. MEXICO FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. MEXICO FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. MEXICO FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA FINASTERIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA FINASTERIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA FINASTERIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA FINASTERIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA FINASTERIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 355. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2024 (USD MILLION)
TABLE 356. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2025-2030 (USD MILLION)
TABLE 357. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2024 (USD MILLION)
TABLE 358. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2025-2030 (USD MILLION)
TABLE 359. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 360. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 363. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 364. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 365. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 366. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 367. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Finasteride market report include:
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Limited
  • Lupin Limited
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Alembic Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 126.55 Million
Forecasted Market Value ( USD ) by 2030 $ 145.44 Million
Compound Annual Growth Rate2.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Finasteride Preparations Market by Dosage Form (Oral Tablet, Topical), Strength (1 Mg, 5 Mg), Distribution Channel, Indication, End User - Global Forecast 2025-2030 - Product Image

Finasteride Preparations Market by Dosage Form (Oral Tablet, Topical), Strength (1 Mg, 5 Mg), Distribution Channel, Indication, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Melanocortin Receptor Agonist Drugs Market by Molecule Type (Branded, Generic), Route of Administration (Injectable, Intranasal, Oral), Indication, Dosage Form, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Melanocortin Receptor Agonist Drugs Market by Molecule Type (Branded, Generic), Route of Administration (Injectable, Intranasal, Oral), Indication, Dosage Form, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Image

Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Image

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Cyproterone Acetate - Global Strategic Business Report - Product Image

Cyproterone Acetate - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From

About the Finasteride Market

Finasteride is a drug used to treat endocrine and metabolic disorders. It is a type II 5-alpha reductase inhibitor, which works by blocking the enzyme responsible for converting testosterone to dihydrotestosterone (DHT). This helps to reduce the symptoms of conditions such as benign prostatic hyperplasia (BPH) and male pattern baldness. Finasteride is also used to treat hirsutism, a condition characterized by excessive hair growth in women. Finasteride is available in both oral and topical formulations. Oral finasteride is typically prescribed for BPH and male pattern baldness, while topical finasteride is used to treat hirsutism. Finasteride is generally well-tolerated, with few side effects. The Finasteride market is a growing one, with many companies offering products for the treatment of endocrine and metabolic disorders. Some of the major players in the market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, and Mylan N.V. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.